Fusarium head blight (FHB), or scab, of small grains (such as barley and wheat) is a serious disease that reduces crop productivity and can result in mycotoxin contamination. When infected, harvested grains may contain trichothecene mycotoxin such as deoxynivalenol (DON) or nivalenol (NIV), as well as their acetyl derivatives (and/or zearalenone), which are commonly found in grains worldwide ([@b7-ppj-30-33]; [@b25-ppj-30-33]; [@b32-ppj-30-33]).

A major causal agent of FHB is the member of the *Fusarium graminearum* species complex (FGSC), which contains over 15 phylogenetically distinct species (also known as lineages), including *F. graminearum* and *F. asiaticum* ([@b23-ppj-30-33]; [@b24-ppj-30-33]; [@b30-ppj-30-33]). Among these species, *F. graminearum* is ubiquitously distributed around the world ([@b3-ppj-30-33]; [@b31-ppj-30-33]), while *F. asiaticum* is frequently found in Asia, including Korea and Japan ([@b11-ppj-30-33]; [@b17-ppj-30-33]; [@b19-ppj-30-33]).

*Fusarium graminearum* and *F. asiaticum* share morphological, cultural, and molecular characteristics, and even toxicology. Generally, *F. graminearum* strains produce DON and its acetyl derivatives (3-ADON or 15-ADON), while *F. asiaticum* strains produce NIV and its acetyl derivative (4-ANIV). Both mycotoxins belong to tricyclic sesquiterpenes and share the type B trichothecene backbone, which is mostly synthesized by enzymes and regulators encoded by the genes (*TRI*) located at the trichothecene biosynthetic gene cluster ([@b3-ppj-30-33]). Differences in chemical structure between DON and NIV (i.e., presence or absence of hydroxyl group at the C4 position) originated from nucleotide variations in the two *TRI* genes (*TRI13* and *TRI7*) between two chemotype strains ([@b20-ppj-30-33]; [@b18-ppj-30-33]). NIV is known to be more toxic than DON ([@b6-ppj-30-33]) and to exert a synergistic effect when mixed with DON ([@b28-ppj-30-33]). In addition, the quantity of each trichothecene differs between DON and NIV strains; the relative amount of DON produced by a DON-producing FGSC isolate (typically *F. graminearum*) is higher than that of NIV by a NIV-producing *F. asiaticum* isolate. These species are normally simultaneously present in host crops in Korea. Due to the more frequent occurrence and resulting economic loss, DON is better characterized than NIV.

At this time, extensive comparisons between NIV and DON strains have been performed for genes controlling trichothecene production and sexual reproduction, such as those located at the mating type (*MAT*) loci ([@b12-ppj-30-33]) and trichothecene gene clusters ([@b15-ppj-30-33]; [@b20-ppj-30-33]). These studies have revealed more than 80% nucleotide similarity between the two chemotype strains. As described above, nucleotide polymorphisms of *TRI13* and *TRI7* are known to determine trichothecene chemotypes of *F. graminearum* and *F. asiaticum* ([@b20-ppj-30-33]; [@b18-ppj-30-33]). Alterations in individual *MAT* gene expression is thought to be due to variations in self-fertility between two chemotype strains; the majority of NIV-producing *F. asiaticum* showed a lower self-fertility than the highly fertile DON-producing *F. graminearum* strains ([@b12-ppj-30-33]; [@b17-ppj-30-33], 2012). At this time, genome sequencing of a Korean *F. asiaticum* strain is almost complete, which will allow comparisons to be made at the whole genome level (Yun et al., unpublished data). However, the quantitative difference in trichothecene production by two chemotype strains has not been explored. Therefore, we compared the expression of members of the *TRI* gene clusters in DON- and NIV-producing strains to determine whether differences in the *TRI* gene expression level contribute to the differential ability of the two chemotype strains to produce trichothecenes.

Materials and Methods
=====================

Fungal strains and nucleic acid preparation
-------------------------------------------

Six strains were used for comparison. Among the four DON-producing *F. graminearum* strains, PH-1 ([@b29-ppj-30-33]) and H-11 ([@b20-ppj-30-33]) were 15 acetyl DON (15-ADON) producers, while H7-4 and H7-11 were 3 acetyl DON (3-ADON) producers. PH-1 was isolated from wheat in the United States, H-11 from corn, and H7-4 and H7-11 from barley grown in Korea. *Fusarium asiaticum* strains SCK04 ([@b13-ppj-30-33]) and R308, which were isolated from Korean barley and rice, respectively, produce NIV and 4 acetyl NIV (4-ANIV) simultaneously. All Korean strains are available upon request. For trichothecene production, fungal strains were grown in a defined liquid medium (1 g, KH~2~PO~4~, 0.5 g MgSO~4~· 7H~2~O, 0.5 g KCl, 1.14 g agmatine sulfate, 30 g sucrose, 0.2 ml trace elements, and distilled water to 1 L; [@b8-ppj-30-33]; [@b21-ppj-30-33]) for 14 days, and mycelia were harvested every 2 days. All cultures were replicated three times. Mycelia were used for nucleic acid extraction, and culture liquid was saved for toxin analysis. Fungal genomic DNA was extracted as described previously ([@b21-ppj-30-33]). Total RNA was extracted from the mycelial mat using the easy-spin™ total RNA Extraction Kit (iNtRON Biotechnology, Daejeon, Korea) according to the manufacturer's protocol. Total RNA (5 μg) was used to synthesize cDNA using the SuperScript III First-Strand Synthesis System for reverse transcription-polymerase chain reaction (RT-PCR; Invitrogen, Carlsbad, CA, USA).

Quantitative real-time PCR
--------------------------

Twelve *TRI* genes were analyzed ([Table 1](#t1-ppj-30-33){ref-type="table"}). To determine the expression level of each gene, a set of gene-specific PCR primers spanning the coding regions of each gene was designed using the Primer3 Program (<http://bioinfo.ut.ee/primer3-0.4.0/>; [Table 1](#t1-ppj-30-33){ref-type="table"}). As an endogenous gene, translation elongation factor 1 alpha (*EF1α*) was selected among several housekeeping genes as a control ([@b14-ppj-30-33]). Quantitative real-time PCR (qPCR) reactions were performed in an iCycler iQ5™ Real Time PCR Detection System (Bio-Rad, Hercules, CA, USA). The PCR thermal cycling conditions were as follows: 95°C for 3 min, followed by 45 cycles at 95°C for 10 s, 60°C for 20 s, 72°C for 20 s, and finally 95°C for 10 s and 65°C for 5 s. The PCR reaction contained 10 μl of 2× iQ SYBR^®^ Green Supermix (Bio-Rad), 0.5 μl of each primer (10 pM), 1 μl of template cDNA (12.5 ng), and sterile bi-distilled water to a final volume of 20 μl. Quantification values were automatically determined using the Bio-Rad CFX Manager version 1.6, and the threshold cycle (Ct) values were determined. The standard curve represents a plot of the Ct versus log DNA concentration. In all experiments, appropriate negative controls containing no template were subjected to the same procedure to exclude or detect DNA contamination. Each sample was amplified in duplicate with three repeats in every experiment, and final Ct values are presented as an average. Relative levels of the genes were calculated by comparing the Ct values using *EF1α* as the endogenous reference and assigning the gene expression level on day 2 in PH-1 (*FPP*, *TRI4*, *TRI5*, *TRI6*, *TRI10*, *TRI11*, *TRI12*, and *TRI101*) and H-11 (*TRI3*, *TRI8*, *TRI9*, and *TRI14*) as 1 (Table 3).

Northern analysis
-----------------

Gene expression was also analyzed using Northern analysis. To prepare probes, each *TRI* gene was amplified with the qPCR primers noted above and purified using a QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany). Northern analysis was performed using standard methods ([@b27-ppj-30-33]).

Toxin analysis
--------------

Each agmatine-amended liquid culture was filtered through filter paper (No. 1; Whatman, Maidstone, Kent, UK), and 500 μl of the filtrate was directly used in mixture preparation with acetonitrile:water (1:1) solution for liquid chromatography/mass spectrometry (LC/MS) analysis (Hewlett-Packard, Palo Alto, CA, USA). The culture samples were screened for the production of DON, NIV, and their acetyl derivatives (15-ADON, 3-ADON, and 4-ANIV), as described previously ([@b19-ppj-30-33]).

Statistical analysis
--------------------

To analyze changes over time in gene expression by each strain, a general linear model (GLM) was used for the one-way analysis of variance (ANOVA). When the null hypothesis was rejected (*P* \< 0.05), means were compared using Duncan's multiple range tests. The same procedure was also applied to compare the amount of toxin produced by all tested strains at one specific time point. All statistical analysis was performed using SAS Enterprise Guide 4.3 (SAS Institute, Cary, NC, USA).

Results
=======

Toxin accumulation by strains during culture
--------------------------------------------

For all fungal strains examined (excluding H7-4), both DON and NIV production were initially detected at days 4 or 6, and their accumulation gradually peaked at day 12 or 14 ([Fig. 1](#f1-ppj-30-33){ref-type="fig"}). In contrast, production patterns of their acetyl derivatives (3-ADON, 15-ADON, or 4-ANIV) differed from the nonacetyl forms as the toxin induction and the peak level was observed at least 2 days earlier; the toxin levels continuously decreased after peaking ([Fig. 1](#f1-ppj-30-33){ref-type="fig"}). However, the patterns observed in strains PH-1, H7-4, and H7-11 were slightly biased as second peaks occurred at day 8. Quantities of total trichothecenes (DON + acetyl forms) produced in three *F. graminearum* strains (PH-1, H7-4, and H7-11) did not fluctuate significantly between the fungal strains, ranging from 13.5 to 29.0 μg ml^−1^; H-11 produced more trichothecenes (∼1.7--3.5-fold higher) than the other three strains. One NIV-producing *F. asiaticum* SCKO4 strain also produced a similar level of trichothecenes (NIV + 4-ANIV), while the other *F. asiaticum* R308 produced significantly lower (5.6--20.0-fold) amounts of trichothecene than DON producers and SCKO4 ([Fig. 1](#f1-ppj-30-33){ref-type="fig"}).

Comparison of gene expression
-----------------------------

Relative expression of a specific gene determined by qPCR among the strains was statistically compared ([Table 2](#t2-ppj-30-33){ref-type="table"}), and the results supported the patterns shown in [Fig. 2](#f2-ppj-30-33){ref-type="fig"}. Based on both qPCR and Northern hybridization data, transcript accumulations of the *TRI* genes could be categorized into at least four patterns. First, six *TRI* genes (*TRI4*, *TRI5*, *TRI6*, *TRI10*, *TRI11*, and *TRI12*) showed an early induction in most strains (excluding *F. asiaticum* R308, which was a poor NIV producer and showed very low basal expression levels throughout the entire incubation time). qPCR analysis showed that the gene expression peaked at day 2, abruptly decreased at day 4, and stayed low until day 14 ([Fig. 2](#f2-ppj-30-33){ref-type="fig"}). Northern data clearly supported this type of gene expression in *TRI4* and *TRI5* ([Fig. 3](#f3-ppj-30-33){ref-type="fig"}). Based on the qPCR data, *F. graminearum* PH-1 showed a slightly different pattern from the other strains for five genes (*TRI5*, *TRI6*, *TRI10*, *TRI11*, and *TRI12*), in which the transcript accumulation peaked at day 4 instead of day 2. However, Northern hybridization analysis supported that the gene expression of *TRI4* and *TRI5* in PH-1 were consistent with other strains in this group. Despite the earlier expression, several fungal strains showed variations at later points. Unlike the DON-producing *F. graminearum* strains, both NIV-producing *F. asiaticum* strains SCKO4 and R308 maintained significant expression levels of *TRI6* and *TRI10* during the relatively late incubation periods, showing two expression peaks at days 2 or 4 and 12 or 14 ([Fig. 2](#f2-ppj-30-33){ref-type="fig"}, [Table 2](#t2-ppj-30-33){ref-type="table"}). In addition, the *TRI12* transcript reached the second peak on day 10 in 15-ADON-producing *F. graminearum* strains (H-11 and PH-1). Second, the *FPP* gene showed a middle induction period in all strains, but a slight difference was noted between *F. graminearum* and *F. asiaticum*. In *F. graminearum*, the gene expression was significantly detected on day 2, peaked at days 6 or 8, and gradually decreased until day 14, while the expression levels significantly decreased after day 6 in *F. asiaticum*. The *F. asiaticum*-specific expression pattern was also demonstrated based on Northern hybridization. Third, *TRI101* could be grouped as a relatively constitutive expression type in all strains, excluding *F. asiaticum* R308, which showed a constant expression during the late incubation periods (days 8--14), although the expression levels were relatively low. Fourth, the remaining *TRI* genes (*TRI3*, *TRI8*, *TRI9*, and *TRI14*) showed no significant level of transcript accumulation during the entire incubation period in any strain, excluding *F. asiaticum* SCKO4. Notably, these *TRI* genes were expressed with the early induction pattern in only SCKO4. *TRI7* and *TRI13* were excluded from the comparison because they were directly involved in NIV synthesis and defective in DON production.

Discussion
==========

The trichothecene accumulation pattern revealed that acetyl derivatives (15-ADON, 3-ADON, or 4-ANIV) were detected first, followed by non-acetylated forms (DON or NIV). Acetylated trichothecenes peaked at day 4, while the synthesis of non-acetylated forms continued increasing. This pattern was expected since acetyl derivatives are known to form before the non-acetyl forms ([@b3-ppj-30-33]). Timing of toxin production was also similar to the previous analyses in barley ([@b1-ppj-30-33]), wheat ([@b9-ppj-30-33]), and liquid culture ([@b4-ppj-30-33]; [@b10-ppj-30-33]; [@b22-ppj-30-33]). Thus, no difference occurred in the induction timing of trichothecene production between DON and NIV in any strains examined. Gene expression profiling revealed that the expression of most *TRI* genes were induced 2 days earlier when compared to time-course toxin accumulation, indicating that high levels of *TRI* transcript accumulation is a prerequisite for initiating the biosynthetic pathway of DON or NIV. In this regard, the early induction patterns of six *TRI* genes (*TRI4*, *TRI5*, *TRI6*, *TRI10*, *TRI11*, and *TRI12*) in the high trichothecene producers, and the other four genes (*TRI3*, *TRI8*, *TRI9*, and *TRI14*) in only SCKO4, strongly support that two transcriptional regulators encoded by *TRI6* and *TRI10* positively regulated the expression of these *TRI* genes, leading to the synthesis of metabolic enzymes and other proteins required for trichothecene production in both *F. graminearum* and *F. asiaticum*. Considering the strong transcript signals of *TRI3* and *TRI8* based on Northern analysis of *F. sporotrichioides* ([@b26-ppj-30-33]), the possibility exists that the lack of detectable gene expression in the second set of *TRI* genes (*TRI3*, *TRI8*, *TRI9*, and *TRI14*) in the DON-producing *F. graminearum* could have been due to experimental artifacts. Based on this information, their expression patterns would be the early induction type, similar to SCKO4.

The availability of detailed gene expression profiles among different trichothecene chemotypes allowed us to identify the possible chemotype-specific gene expression patterns. The most significant difference between DON and NIV producers was observed in the transcription regulator-encoding *TRI* genes (*TRI6* and *TRI10*): the maintenance of gene expression during the late incubation periods (i.e., days 10--14) in both NIV producers (SCKO4 and R308), as well as the early induction in SCKO4 (*TRI6*) or SCKO4 and R308 (*TRI10*). Similarly, *TRI101* encoding trichothecene 3-*O*-acetyltransferase was expressed during the same late periods in only two NIV producers. In contrast, the expression levels of *FPP*-encoding farnesyl pyrophosphate synthetase were restricted during the early incubation times (days 2--6) in both NIV producers, while the gene expression was maintained until day 10 in DON producers. These variations were specific to NIV-producing *F. asiaticum* strains since they were mostly observed in two NIV producers regardless of the quantities of NIV they produced. Moreover, SCKO4 is a relatively high trichothecene producer. However, further investigations are required to confirm that these differences are associated with genetic diversity between DON- and NIV-producing species of the FGSC. Excluding these cases, no significant difference was observed at the transcriptional level in the early-induced genes between three DON-producing *F. graminearum* strains, and one NIV-producing *F. asiaticum* SCKO4 strain that produced trichothecenes at similar levels as the DON producers. This indicated that the amount of trichothecene accumulated in agmatine-amended liquid medium is proportional to the expression level of *TRI* genes, regardless of the DON/NIV chemotypes. In this regard, the observation that the amount of NIV produced by *F. asiaticum* is lower than that of DON by *F. graminearum* may be due to the relatively lower levels of *TRI* gene expression in *F. asiaticum* than *F. graminearum*. To confirm this hypothesis, more NIV-producing *F. asiaticum* should be investigated for *TRI* gene expression under various culture conditions, including solid cereal plants. Additionally, exploring the regulatory networks is important, including signal transduction pathways controlling the biosynthetic pathway for trichothecene production, to explore the genetic elements responsible for the difference in trichothecene quantities between the two chemotypes. In addition to the NIV-specific gene expression, a possible 15-ADON-specific pattern was observed for *TRI12* encoding a trichothecene efflux pump. The expression levels of this pump reached a second peak at day 10 only in *F. graminearum* PH-1 and H-11, although the expression levels were lower than at days 2 or 4.

In conclusion, the expression levels of most *TRI* genes essential for trichothecene production in both *F. graminearum* and *F. asiaticum* were strongly induced at early incubation times (i.e., 2 days after inoculation) before toxin biosynthesis. NIV chemotype-specific gene expression patterns were identified for two transcriptional regulator genes (*TRI6* and *TRI10*), and the lower NIV production in *F. asiaticum* may be due to the lower expression levels of *TRI* genes in *F. asiaticum* relative to *F. graminearum*.
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![Toxin accumulation by DON and NIV strains in agmatine-amended liquid medium. Vertical bars indicate the standard deviation of the observed values at the time point.](ppj-30-33f1){#f1-ppj-30-33}

![Transcript accumulation of individual *TRI* genes in agmatine-amended liquid medium based on qPCR. The *x*-axis represents days (d) after inoculation for trichothecene production in liquid medium. The *y*-axis represents relative amounts of transcripts. Data for each gene are shown in two separate graphs; left in each set show the entire graph, and an enlarged graph for the indistinct data is shown on the right. The positions and nucleotide sequences of the primers used in qPCR are shown in [Table 1](#t1-ppj-30-33){ref-type="table"}. Data shown are the mean values obtained from three independent biological samples, and detailed statistical information is shown in [Table 2](#t2-ppj-30-33){ref-type="table"}.](ppj-30-33f2){#f2-ppj-30-33}

![Northern blots of *F. graminearum* and *F. asiaticum* strains probed with four genes located the trichothecene gene cluster. Incubation times (days after inoculation) are indicated above the gels.](ppj-30-33f3){#f3-ppj-30-33}

###### 

Genes analyzed and primers used in the study

  ---------------------------------------------------------------------------------------------------------
  Gene (Ref)                    Function                                    Forward primer (5′→3′)
  ----------------------------- ------------------------------------------- -------------------------------
  *FPP* ([@b3-ppj-30-33])       Farnesyl phyrophosphate synthase            TTTGGCAAGCCCGAACACATT\
                                                                            GCGGATCTGGCCAACAACCTTCT

  *TRI3* ([@b16-ppj-30-33])     Trichothecene 15-O-acetyltransferase        CTTGCAGGGATATCAAGAAATGTTACGA\
                                                                            CTCGCCTGTTGTAGTTCGCTTGATTT

  *TRI4* ([@b16-ppj-30-33])     Trichodiene oxygenase                       TCGAGGCACAACAGAAGGGTATCC\
                                                                            AATGTCGGCCTTGGTGGTGTC

  *TRI5* ([@b3-ppj-30-33])      Trichodiene synthase                        CCAGGAAACCCTACACTCGTCTAAG\
                                                                            TGGCCGCCTGCTCAAAGAAC

  *TRI6* ([@b16-ppj-30-33])     Transcription factor                        GGCATTACCGGCAACACTTCAA\
                                                                            CATGTTATCCACCCTGCTAAAGACC

  *TRI8* ([@b16-ppj-30-33])     Trichothecene 3-O-esterase                  GCTACTTTGGACTCAATTCG\
                                                                            CATACTGTACYGCAAGTTCTG

  *TRI9* ([@b16-ppj-30-33])     Unknown                                     AGCCGCTAAACTGATCGACTCATA\
                                                                            GCTTTGGCTGCGACCCATAT

  *TRI10* ([@b2-ppj-30-33])     Regulatory gene                             GTGGCCGGGACGCTTCAAT\
                                                                            ATCCGTCAAGTCTTCCCATCTCAT

  *TRI11* ([@b16-ppj-30-33])    Isotrichodermin 15-oxygenase                AAGTACTTCACCCGACCAAACGAC\
                                                                            CGGCAAGGCGAATGTCAAAC

  *TRI12* ([@b16-ppj-30-33])    Major facilitator superfamily transporter   TCCACAGTCATCTTTCCCCAGTCT\
                                                                            CTCCCAGTGCCATAGCGAAGTAGT

  *TRI14* ([@b5-ppj-30-33])     Unknown                                     CTGGGAACCTACGCATCAAACATT\
                                                                            CGAATGAGCTGCCCAATGATGT

  *TRI101* ([@b16-ppj-30-33])   Trichothecene 3-O-acetyltransferase         GTGGGACTCTGGGATTACGACTTT\
                                                                            GTCCACTCCTTATCCGCCTTCAA
  ---------------------------------------------------------------------------------------------------------

###### 

Relative amounts of individual *TRI* transcripts in agmatine-amended liquid medium

             Incubation time (days)                                                                                                                                                                                                                  
  ---------- ------------------------ ---------- ---------- ------- ----------- -------- ------- ---------- ---------- ------ ------------- ---------- ------- ------------- -------- ------- ---------- --------- ------ ---------------- --------- -----
  *FPP*      PH-1                     1.00       a/II III   .00     .75         a/I II   .25     4.10       a/V        .00    3.30          a/IV       .06     1.27          ab/III   .03     .60        a/I       .00    .53              a/I       .03
                                                                                                                                                                                                                                                     
             H-11                     1.48       a/II       .11     .57         a/I      .09     1.63       a/II III   .18    1.83          a/II III   .14     1.93          b/III    .20     .60        a/I       .06    .53              a/I       .03
  H7-4       1.50                     a/I        .08        1.63    a/I         1.19     11.57   b/II       2.07       3.33   a/I           2.54       1.10    ab/I          .25      .50     a/I        .04       .50    a/I              .06       
  H7-11      .85                      a/I        .30        .48     a/I         .13      5.95    a/II       3.95       3.00   a/I II        2.13       .68     a/I           .31      .78     a/I        .24       .45    a/I              .16       
  SCK04      2.58                     b/II       .45        1.23    a/I         .30      3.00    a/II       .98        .55    a/I           .23        .60     a/I           .37      .53     a/I        .27       .33    a/I              .11       
  R308       1.57                     a/II       .09        1.08    a/I         .16      3.40    a/III      .23        .73    a/I           .11        .55     a/I           .15      .63     a/I        .18       .63    a/I              .18       
                                                                                                                                                                                                                                                     
  *TRI3*     PH-1                     .03        a/I        .01     .23         b/II     .06     .01        a/I        .01    .01           a/I        .00     .02           a/I      .01     .01        a/I       .00    .01              a/I       .00
  H-11       1.00                     a/III      .00        .07     a/II        .01      .01     a/I        .01        .01    a/I           .00        .01     a/I           .01      .01     a/I        .01       .00    a/I              .00       
  H7-4       .16                      a/II       .01        .02     a/I         .01      .00     a/I        .00        .02    a/I           .01        .01     a/I           .00      .00     a/I        .00       .00    a/I              .00       
  H7-11      .36                      a/II       .09        .04     a/I         .01      .03     a/I        .02        .01    a/I           .01        .07     a/I           .01      .11     ab/I       .06       .07    a/I              .02       
  SCK04      7.78                     b/II       2.36       .28     b/I         .08      .10     b/I        .03        .09    b/I           .04        .57     ab/I          .29      .32     c/I        .08       .72    b/I              .23       
  R308       .02                      a/I        .01        .04     a/I         .02      .11     b/I        .05        .02    a/I           .01        .89     b/II          .57      .18     b/I        .03       .43    b/I II           .11       
                                                                                                                                                                                                                                                     
  *TRI4*     PH-1                     1.00       a/II       .00     .93         ab/II    .28     .03        a/I        .03    .00           a/I        .00     .08           a/I      .03     .00        a/I       .00    .03              a/I       .03
  H-11       24.15                    bc/II      5.63       .90     ab/I        .20      .08     a/I        .03        .00    a/I           .00        .03     a/I           .03      .00     a/I        .00       .00    a/I              .00       
  H7-4       13.45                    ab/II      2.43       .13     a/I         .06      .05     a/I        .03        .05    a/I           .05        .00     a/I           .00      .03     a/I        .03       .05    a/I              .03       
  H7-11      8.75                     a/II       2.32       .53     a/I         .18      .08     a/I        .03        .15    a/I           .10        .15     a/I           .06      .08     a/I        .05       .23    a/I              .09       
  SCK04      29.90                    c/II       9.71       4.13    c/I         2.54     .23     a/I        .13        .13    a/I           .05        .85     a/I           .65      2.13    a/I        1.83      1.75   a/I              1.36      
  R308       .15                      a/I II     .03        .15     a/I II      .03      .18     a/I II     .06        .08    a/I           .03        .28     a/I II        .09      .38     a/II       .15       .33    a/I II           .11       
                                                                                                                                                                                                                                                     
  *TRI5*     PH-1                     1.00       a/I        .00     2.87        ab/II    1.75    .45        ab/I       .14    .40           a/I        .12     .83           a/I      .39     .18        a/I       .06    .78              a/I       .44
  H-11       48.23                    c/II       1.26       1.40    a/I         .37      .60     ab/I       .19        .23    a/I           .06        .70     a/I           .39      .13     a/I        .03       .23    a/I              .10       
  H7-4       16.57                    b/II       3.03       .88     a/I         .21      .78     ab/I       .42        .90    ab/I          .34        .30     a/I           .11      .40     a/I        .23       .58    a/I              .35       
  H7-11      12.63                    b/II       5.36       8.60    b/I II      4.42     1.28    b/I        .61        1.75   b/I           .60        3.08    b/I           1.69     3.28    b/I        1.93      3.80   b/I II           1.87      
  SCK04      .23                      a/II       .09        .08     a/I         .03      .00     a/I        .00        .03    a/I           .03        .08     a/I           .03      .10     a/I        .04       .10    a/I              .04       
  R308       .00                      a/I        .00        .00     a/I         .00      .00     a/I        .00        .00    a/I           .00        .03     a/I II        .03      .03     a/I II     .03       .08    a/II             .03       
                                                                                                                                                                                                                                                     
  *TRI6*     PH-1                     1.00       ab/I       .00     10.80       b/II     4.45    .25        a/I        .09    .15           ab/I       .06     .15           ab/I     .05     .05        a/I       .03    .15              a/I       .06
  H-11       6.83                     d/III      .95        1.80    a/II        .42      .28     a/I        .05        .10    a/I           .00        .13     a/I           .06      .05     a/I        .03       .08    a/I              .05       
  H7-4       1.47                     b/II       .22        .43     a/I         .20      .15     a/I        .05        .33    ab/I          .17        .10     a/I           .00      .10     a/I        .00       .20    a/I              .04       
  H7-11      1.03                     ab/II      .13        1.90    a/III       .40      .25     a/I        .05        .30    ab/I          .20        .55     b/I II        .19      .17     a/I        .07       .48    a/I II           .13       
  SCK04      3.30                     c/III      .00        2.30    a/II III    .29      .70     a/I        .40        .53    b/I           .14        .50     ab/I          .12      1.37    b/I II     .49       1.30   b/I II           .52       
  R308       .13                      a/I        .03        .43     a/I II      .06      .33     a/I II     .12        .20    ab/I          .04        1.50    c/III         .25      .83     b/II       .41       1.53   b/III            .20       
                                                                                                                                                                                                                                                     
  *TRI8*     PH-1                     .01        a/I        .01     .22         a/II     .06     .07        a/III      .02    .13           ab/I II    .06     .48           ab/III   .10     .08        ab/I II   .02    .09              ab/I II   .02
  H-11       1.00                     b/III      .00        .61     a/II        .14      .42     b/II       .09        .16    b/I           .06        .09     a/I           .03      .11     b/I        .05       .10    ab/I             .03       
  H7-4       .10                      a/II       .01        .02     a/I         .01      .01     a/I        .00        .02    a/I           .01        .01     a/I           .00      .01     a/I        .00       .01    a/I              .00       
  H7-11      .08                      a/III IV   .02        .03     a/III III   .01      .02     a/I II     .01        .01    a/I           .00        .08     a/II III IV   .01      .10     ab/IV      .03       .07    ab/I II III IV   .02       
  SCK04      2.56                     c/II III   .31        3.42    b/III       1.34     .83     c/I        .16        .20    b/I           .05        1.09    b/I II        .51      .41     c/I        .03       .61    c/I              .17       
  R308       .24                      a/I        .10        .26     a/I         .05      .19     a/I        .04        .07    ab/I          .02        .44     ab/I          .27      .12     b/I        .02       .30    b/I              .06       
                                                                                                                                                                                                                                                     
  *TRI9*     PH-1                     .07        a/II       .02     .19         a/III    .03     .01        a/I        .00    .01           a/I        .00     .01           a/I      .01     .00        a/I       .00    .01              ab/I      .01
  H-11       1.00                     b/III      .00        .19     a/II        .06      .01     a/I        .01        .00    a/I           .00        .02     a/I           .02      .00     a/I        .00       .00    a/I              .00       
  H7-4       .39                      ab/I       .07        .27     a/II III    .16      .02     a/I        .01        .08    b/III         .03        .07     a/III         .04      .01     a/I        .01       .02    ab/I             .01       
  H7-11      .54                      ab/II      .16        .19     a/I         .09      .09     b/I        .04        .02    a/I           .01        .07     a/I           .02      .13     b/I        .08       .09    b/I              .03       
  SCK04      2.40                     c/II       .52        .33     a/I         .13      .08     b/I        .02        .03    a/I           .02        .17     a/I           .10      .08     ab/I       .02       .17    c/I              .05       
  R308       .09                      a/I        .04        .12     a/I         .03      .02     a/I        .01        .01    a/I           .01        .13     a/I           .09      .02     a/I        .01       .07    ab/I             .02       
                                                                                                                                                                                                                                                     
  *TRI10*    PH-1                     1.00       a/I        .00     34.18       b/II     11.44   .20        a/I        .09    .13           a/I        .05     .25           a/I      .13     .05        a/I       .03    .23              a/I       .14
  H-11       7.40                     a/III      1.21       3.17    a/II        .43      .10     a/I        .00        .10    a/I           .04        .00     a/I           .00      .05     a/I        .03       .03    a/I              .03       
  H7-4       .60                      a/II III   .17        .70     a/III       .38      .15     a/I II     .09        .25    ab/I II III   .13        .03     a/I           .03      .05     a/I        .05       .00    a/I              .00       
  H7-11      .35                      a/I        .19        .70     a/I         .29      .28     a/I        .21        .25    ab/I          .10        .30     a/I           .17      .30     a/I        .30       .68    a/I              .51       
  SCK04      17.83                    b/II       4.84       19.13   ab/II       5.64     4.83    b/I        1.77       .60    b/I           .25        3.13    b/I           1.13     6.60    b/I        4.01      5.13   b/I              2.56      
  R308       2.60                     a/II       .00        2.87    a/II        .61      .55     a/I II     .26        .20    ab/I          .14        1.28    ab/I II       .95      1.58    a/I II     .77       1.55   a/I II           1.06      
                                                                                                                                                                                                                                                     
  *TRI11*    PH-1                     1.00       ab/I       .00     6.33        c/II     2.21    .38        ab/I       .09    .33           a/I        .11     .78           a/I      .28     .20        a/I       .00    .63              a/I       .27
  H-11       13.20                    c/III      .35        .78     ab/II       .15      .58     bc/I II    .06        .25    a/I           .05        .55     a/III         .16      .15     a/I        .03       .28    a/I              .06       
  H7-4       15.00                    c/III      .23        1.77    ab/II       .50      .73     c/I II     .14        1.70   b/II          .81        .23     a/I           .03      .45     a/I        .13       1.00   a/I II           .49       
  H7-11      14.87                    c/II       2.11       4.40    bc/I        2.38     .75     c/I        .18        1.90   b/I           .66        2.38    b/I           1.07     1.53    b/I        .75       3.93   b/I              1.28      
  SCK04      2.70                     b/II       .57        .18     a/I         .05      .13     a/I        .06        .10    a/I           .04        .80     a/I           .47      .30     a/I        .12       .30    a/I              .20       
  R308       .03                      a/I        .03        .08     a/I II      .03      .10     a/I II     .04        .03    a/I           .03        .23     a/II          .11      .18     a/I II     .06       .18    a/I II           .06       
                                                                                                                                                                                                                                                     
  *TRI12*    PH-1                     1.00       a/I        .00     8.80        b/II     4.33    .83        b/I        .30    1.68          b/I        .39     2.37          b/I      1.18    .35        ab/I      .06    .28              ab/I      .09
  H-11       21.83                    b/II       7.80       1.78    a/I         .90      .70     b/I        .27        .43    a/I           .15        1.98    ab/I          1.13     .30     ab/I       .13       .28    ab/I             .14       
  H7-4       .08                      a/II       .03        .00     a/I         .00      .00     a/I        .00        .00    a/I           .00        .00     a/I           .00      .00     a/I        .00       .00    a/I              .00       
  H7-11      .03                      a/I II     .03        .13     a/II        .06      .00     a/I        .00        .03    a/I II        .03        .10     ab/I II       .04      .00     a/I        .00       .08    a/I II           .05       
  SCK04      2.60                     a/II       .45        .38     a/I         .09      .38     ab/I       .15        .38    a/I           .13        .43     ab/I          .20      .63     b/I        .26       1.78   b/I II           1.19      
  R308       .13                      a/I        .05        .08     a/I         .03      .60     ab/II      .06        .10    a/I           .04        .37     ab/I II       .18      .65     b/II       .22       .43    ab/I II          .14       
                                                                                                                                                                                                                                                     
  *TRI14*    PH-1                     .04        a/II       .01     .12         c/III    .01     .01        a/I        .00    .00           a/I        .00     .01           a/I      .00     .00        a/I       .00    .00              a/I       .00
  H-11       1.00                     a/III      .00        .10     bc/II       .02      .01     a/I        .00        .00    a/I           .00        .00     a/I           .00      .00     a/I        .00       .00    a/I              .00       
  H7-4       .89                      a/II       .21        .04     ab/I        .03      .01     a/I        .00        .02    a/I           .01        .01     a/I           .01      .00     a/I        .00       .01    a/I              .00       
  H7-11      .23                      a/II       .09        .03     ab/I        .01      .02     a/I        .01        .01    a/I           .01        .07     ab/I          .02      .12     c/III      .05       .12    ab/I II          .06       
  SCK04      5.93                     b/II       1.19       .13     c/I         .04      .07     b/I        .03        .02    a/I           .01        .13     b/I           .06      .11     bc/I       .04       .18    b/I              .07       
  R308       .01                      a/I        .01        .02     a/I         .01      .02     a/I        .02        .01    a/I           .00        .11     ab/II         .05      .03     ab/I       .01       .03    a/I              .01       
                                                                                                                                                                                                                                                     
  *TRI101*   PH-1                     1.00       a/I II     .00     .80         a/I II   .27     .25        a/I        .05    1.47          ab/I II    .29     5.83          a/III    1.48    2.83       a/II      .50    5.08             ab/III    .95
  H-11       3.10                     bc/I       .45        2.77    a/I         .67      6.20    c/III      .27        3.80   b/I II        .47        2.40    a/I           .45      1.70    a/I        .26       5.58   ab/II III        1.18      
  H7-4       3.65                     c/I II     .49        8.57    a/IV        1.01     6.43    c/III IV   1.18       1.83   a/I II        1.13       1.60    a/I           .33      4.43    a/II III   .90       2.87   ab/I II          1.05      
  H7-11      2.20                     b/I        .39        6.00    a/I         1.59     5.05    bc/I       1.28       4.78   b/I           1.23       3.83    a/I           1.83     2.40    a/I        1.76      2.60   ab/I             1.32      
  SCK04      11.50                    d/I        .52        39.67   b/II        7.71     2.93    b/I        1.01       3.10   ab/I          .73        14.20   b/I           4.10     13.03   b/I        4.99      8.43   b/I              4.53      
  R308       .38                      a/I        .06        .20     a/I         .04      .30     a/I        .11        1.20   a/I II        .35        1.30    a/I II        .39      2.08    a/II       .58       1.80   a/II             .55       

Mean with the same letter represents not significantly different in a single gene among all the fungal strains examined at a single time point; mean with the same Roman number represents not significantly different during the entire time points.

SE represents standard errors.

[^1]: These authors contributed equally to this work.
